advisorsecurities master

CTSOCytosorbents Corp.

CSNasdaq (XNAS)·USD

Identity

Security key
13898
Ticker
CTSO
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2005-05-17
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
CTSO

Detail

Enriched 2026-08-14 20:47

Market cap
$23,251,816.76
Shares outstanding (class)
62,842,748
Shares outstanding (weighted)
62,842,748
SIC
3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
129
Location
PRINCETON, NJ
Description

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data